LOS ANGELES, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)PACIFIC HEART LUNG & BLOOD INSTITUTE, founded in 2002, is a small nonprofit that reported $399K in total revenue in fiscal year 2023. Revenue grew 13% year-over-year, indicating healthy expansion. Expenses of $1.4M exceeded revenue, resulting in a 246% operating deficit.
SERVES AS A CENTER OF CROSS-DISCIPLINARY SCIENTIFIC RESEARCH THAT SIGNIFICANTLY CONTRIBUTES TO DISCOVERIES OF NEW TREATMENTS FOR HEART, LUNG, AND BLOOD DISEASES, AND TO PROVIDE A PLATFORM FOR MEDICAL EDUCATION FOR BOTH CONSUMERS AND PROFESSIONALS
DURING THESE DISRUPTIVE TIMES, IT HAS BEEN HARD TO RAISE MONEY, AND DIFFICULT TO FIND QUALIFIED SCIENTISTS TO OVERSEE AND PERFORM THE WORK IN OUR LAB. AFTER EXTENSIVE CONVERSATIONS FAILED TO HAVE...
DURING THESE DISRUPTIVE TIMES, IT HAS BEEN HARD TO RAISE MONEY, AND DIFFICULT TO FIND QUALIFIED SCIENTISTS TO OVERSEE AND PERFORM THE WORK IN OUR LAB. AFTER EXTENSIVE CONVERSATIONS FAILED TO HAVE UCLA TAKE OUR INSTITUTE UNDER ITS WING, THE BOARD OF DIRECTORS, IN ORDER TO ENSURE THAT THE MAJORITY OF THE MONEY RAISED WAS USED TO PERFORM THE PURPOSE OF THE MISSION, DECIDED TO DISSOLVE THE NONPROFIT AND DONATE ITS EQUIPMENT AND MONEY TO THE FOLLOWING INSTITUTES WHO HAVE WELL-OILED MACHINES WITH RESOURCES: 1. UCLA IS A PRESTIGIOUS INSTITUTION RENOWNED FOR ITS COMMITMENT TO EDUCATION, RESEARCH, AND COMMUNITY ENGAGEMENT. OUR GIFT TO UCLAS FOUNDATION WILL BUILD A LEGACY FOR PHLBI TO INCENTIVIZE THE CONTINUATION OF DR. CAMERONS RESEARCH AT UCLAS PUNCH LAB AND HONOR THE LONGTIME COLLABORATION BETWEEN THE TWO ORGANIZATIONS. DR. CAMERONS GOAL IS TO BE ABLE TO RECALIBRATE THE MESOTHELIOMA PATIENTS IMMUNE RESPONSE TO RECOGNIZE AND FIGHT THE CANCER. IN THE PROCESS HE AND HIS TEAM WILL EVALUATE POTENTIAL THERAPIES, INCLUDING HIS LONG-TERM INTEREST IN GENE-MODIFIED MESENCHYMAL STEM CELLS FROM VARIOUS SOURCES. AND:2. OHSU (OREGON HEALTH & SCIENCES UNIVERSITY), A DISTINGUISHED AND NATIONALLY RECOGNIZED UNIVERSITY FOCUSING ON DISCOVERIES TO PREVENT AND CURE DISEASES, AS WELL AS THE TRAINING OF MEDICAL SCIENTISTS AND HEALTHCARE PROFESSIONALS ON PATIENT CARE THAT INCORPORATES THE LATEST ADVANCES. OHSUS CENTER FOR EXPERIMENTAL THERAPIES (CET) IS ACTIVELY ENGAGED IN THE DEVELOPMENT OF NOVEL STRATEGIES TO TREAT MESOTHELIOMA AND OVERCOME RESISTANCE TO CHEMOTHERAPY AND IMMUNOTHERAPIES.TO FACILITATE THIS TRANSITION, WE ARE WORKING CLOSELY WITH OHSU & UCLAS DEVELOPMENT OFFICE TO ENSURE THE PROPER TRANSFER OF FUNDS, ALONG WITH ANY SPECIFIC DESIGNATIONS OR RESTRICTIONS THAT HAVE BEEN MADE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $399,270 | $353,486 | +0.1% |
| Expenses | $1,383,060 | $682,396 | +1.0% |
| Net Income | $-983,790 | $-328,910 | +2.0% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| CLARE CAMERON | PRESIDENT | 40.00 |
Officer
|
$111,826 | $0 | $111,826 |
| KRIS A FAIR | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| YULIA MURZAEVA | MANAGING DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| WARREN SHULMAN | TREASURER | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL ARLEN | SECRETARY | 1.00 |
Director
|
$0 | $0 | $0 |
| N DANN MOSS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2023 | $399,270 | $1,383,060 | $300,251 | $-983,790 |
| 2022 | $353,486 | $682,396 | $1,436,333 | $-328,910 |
| 2021 | $706,290 | $828,088 | $1,954,311 | $-121,798 |
| 2020 | $1,937,157 | $797,648 | $1,997,560 | $1,139,509 |
| 2019 | $765,591 | $856,349 | $717,281 | $-90,758 |
| 2018 | $660,271 | $913,136 | $807,930 | $-252,865 |
Compare PACIFIC HEART LUNG & BLOOD INSTITUTE with other nonprofits in California and across the country.